IP Library Granted Patent US 10,913,960
Granted Patent B2
US 10,913,960 · App. 15/359,932 · Granted Feb 9, 2021

Biotechnological production of omega-functionalised carboxylic acids and esters thereof

Inventors: Steffen Schaffer (Herten, DE); Thomas Haas (Muenster, DE); Wilhelm Bruegging (Haltern am See, DE); Ralf Meier (Dortmund, DE)
Assignee: Evonik Operations GmbH
C12P7/62C12N9/0006C12N9/0077C12N9/1029C12N9/1096C12N15/52C12P7/02C12P7/24C12P7/649C12P7/6436C12Y101/01001C12Y101/01002C12Y101/0302C12Y114/15003C12Y203/01075C12Y203/01084C12Y206/01Y02E50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,913,960
App. No.
15/359,932
Granted
Feb 9, 2021
Kind
B2
Abstract

A microbial cell, which is genetically modified to increase the expression relative to the corresponding genetically unmodified cell of an AlkB alkane hydroxylase (E b ) having an amino acid sequence at least 95% identical with the amino acid sequence of SEQ ID NO: 1 and a wax-ester synthase (E f ) having an amino acid sequence at least 95% identical with the amino acid sequence of SEQ ID NO: 2. The cell does not have a genetic modification that increases formation of a carboxylic acid or a carboxylate ester from a simple carbon source.

Claims (33)

1. A microbial cell, which is genetically modified to increase the expression relative to the corresponding genetically unmodified cell of an AlkB alkane hydroxylase (E b ) having an amino acid sequence at least 95% identical with the amino acid sequence of SEQ ID NO: 1 and a wax-ester synthase (E f ) having an amino acid sequence at least 95% identical with the amino acid sequence of SEQ ID NO: 2,

wherein the cell does not comprise a genetic modification that increases formation of a carboxylic acid or a carboxylate ester from a simple carbon source.

2. The cell according to claim 1 ,

wherein the AlkB alkane hydroxylase (E b ) has the amino acid sequence of SEQ ID NO:1, and

the wax-ester synthase (E f ) has the amino acid sequence of SEQ ID NO:2.

3. The cell according to claim 2 ,

wherein the cell is further genetically modified to increase the expression relative to the corresponding genetically unmodified cell of Escherichia coli FadD.

4. The cell according to claim 1 , wherein the cell is selected from the group consisting of Escherichia coli, Pseudomonas sp., Pseudomonas fluorescens, Pseudomonas putida, Pseudomonas stutzeri, Acinetobacter sp., Burkholderia sp., Burkholderia thailandensis, Cyanobakterien, Klebsiella sp., Klebsiella oxytoca, Salmonella sp., Rhizobium sp. and Rhizobium meliloti, Bacillus sp., Bacillus subtilis, Clostridium sp., Corynebacterium sp., Corynebacterium glutamicum, Brevibacterium sp., Chlorella sp. and Nostoc sp.

5. The cell according to claim 4 , wherein

the AlkB alkane hydroxylase (E b ) has an amino acid sequence at least 99% identical with the amino acid sequence of SEQ ID NO:1; and

the wax-ester synthase (E f ) has an amino acid sequence at least 99% identical with the amino acid sequence of SEQ ID NO:2.

6. The cell according to claim 5 , wherein the cell is further genetically modified to increase the expression relative to the corresponding genetically unmodified cell of Escherichia coli FadD.

7. The cell according to claim 1 , wherein the cell is Escherichia coli and is genetically modified to have at least one vector comprising at least one gene encoding the AlkB alkane hydroxylase (E b ) and the wax-ester synthase (E f ) such that the expression of the AlkB alkane hydroxylase (E b ) and the wax-ester synthase (E f ) is increased.

8. The cell according to claim 4 ,

wherein the AlkB alkane hydroxylase (E b ) has the amino acid sequence of SEQ ID NO:1, and

the wax-ester synthase (E f ) has the amino acid sequence of SEQ ID NO:2.

9. The cell according to claim 8 ,

wherein the cell is further genetically modified to increase the expression relative to the corresponding genetically unmodified cell of Escherichia coli FadD.

10. The cell according to claim 1 , wherein the AlkB alkane hydroxylase (E b ) has an amino acid sequence at least 98% identical with the amino acid sequence of SEQ ID NO:1; and

the wax-ester synthase (E f ) has an amino acid sequence at least 98% identical with the amino acid sequence of SEQ ID NO:2.

11. The cell according to claim 1 , wherein

the AlkB alkane hydroxylase (E b ) has an amino acid sequence at least 99% identical with the amino acid sequence of SEQ ID NO:1; and

the wax-ester synthase (E f ) has an amino acid sequence at least 99% identical with the amino acid sequence of SEQ ID NO:2.

12. The cell according to claim 1 , wherein the cell is further genetically modified to increase the expression relative to the corresponding genetically unmodified cell of an acyl-CoA synthetase.

13. The cell according to claim 1 , wherein the cell is further genetically modified to increase the expression relative to the corresponding genetically unmodified cell of Escherichia coli FadD.

14. The cell according to claim 4 , wherein the AlkB alkane hydroxylase (E b ) has an amino acid sequence at least 98% identical with the amino acid sequence of SEQ ID NO: 1; and

the wax-ester synthase (E f ) has an amino acid sequence at least 98% identical with the amino acid sequence of SEQ ID NO: 2.

15. The cell according to claim 4 , wherein the cell is further genetically modified to increase the expression relative to the corresponding genetically unmodified cell of an acyl-CoA synthetase.

16. The cell according to claim 1 , wherein the cell is further genetically modified to increase the expression relative to the corresponding genetically unmodified cell of enzyme E 7 , wherein the enzyme E 7 is capable of converting an ω-oxo alkanoic acid ester to a corresponding ω-amino alkanoic acid ester, and wherein the enzyme E 7 is an ω-transaminase (E h ).

17. The cell according to claim 16 , wherein the ω-transaminase (E h ) has an amino acid sequence at least 95% identical with the amino acid sequence of SEQ ID NO:3.

18. A method of producing at least one ω-functionalized carboxylic acid ester, comprising contacting the microbial cell according to claim 1 with an aqueous solution comprising an alkane, wherein

(a) the alkane comprises dodecane, and the at least one ω-functionalized carboxylic acid ester comprises at least one selected from the group consisting of 12-amino lauric acid methyl ester, 12-hydroxy lauric acid methyl ester, 12-carboxy lauric acid methyl (di) ester, and lauric acid methyl ester, or

(b) the alkane comprises undecane, and the at least one ω-functionalized carboxylic acid ester comprises at least one selected from the group consisting of 11-amino undecanoic acid methyl ester, 11-hydroxy undecanoic acid methyl ester, 11-carboxy undecanoic acid methyl (di) ester, and undecanoic acid methyl ester.

Assignments (2)
CHANGE OF NAME Recorded Jan 31, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051765/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2017
From: SCHAFFER, STEFFEN; HAAS, THOMAS; BRUEGGING, WILHELM; MEIER, RALF
To: EVONIK DEGUSSA GMBH
Reel/Frame 041145/0825 →
Priority Claims (1)
EP 15196180 · Nov 25, 2015 · regional
Continuity (1)
Related Publication 20170145448A1 · May 25, 2017